Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.
about
Prevalence, Risk Factors, and Clinical Relevance of Fluoroquinolone-Resistant Organisms in Rectal Cultures: Should We Target Antibiotic Prophylaxis Prior to Prostate Biopsy?Evaluation of targeted antimicrobial prophylaxis for transrectal ultrasound guided prostate biopsy: a prospective cohort trialRapid Identification of Rectal Multidrug-resistant Escherichia coli Before Transrectal Prostate Biopsy.Prevention and treatment of biopsy-related complications.Sepsis and 'superbugs': should we favour the transperineal over the transrectal approach for prostate biopsy?Reducing the risk of infection for transrectal prostate biopsy with povidone-iodine: a systematic review and meta-analysis.Increase of prostate biopsy-related bacteremic complications in southern Finland, 2005-2013: a population-based analysis.Zero hospital admissions for infection after 577 transperineal prostate biopsies using single-dose cephazolin prophylaxis.Infection after transrectal ultrasound-guided prostate biopsy.The efficacy of duration of prophylactic antibiotics in transrectal ultrasound guided prostate biopsy.The global burden of major infectious complications following prostate biopsy.Significant impact of transperineal template biopsy of the prostate at a single tertiary institution.Reducing Infectious Complications Following Transrectal Ultrasound-guided Prostate Biopsy: A Systematic Review.Prevention of infectious complications after prostate biopsy procedure.Complications after prostate biopsies in men on active surveillance and its effects on receiving further biopsies in the Prostate cancer Research International: Active Surveillance (PRIAS) study.Fosfomycin: a good alternative drug for prostate biopsy prophylaxis the results of a prospective, randomized trial with respect to risk factors.Risk factors for and prophylactic effect of povidone-iodine rectal cleansing on infectious complications after prostate biopsy: a retrospective cohort study.[Spectrum of pathogens in postoperative complications of visceral surgery : The problem of multidrug resistance].Prevalence and characteristics of fecal antimicrobial-resistant Escherichia coli in a cohort of Japanese men undergoing prostate biopsy.A single 80 mg intravenous gentamicin dose prior to prostate needle biopsy does not reduce procedural infectious complicationsAn antimicrobial prophylaxis protocol using rectal swab cultures for transrectal prostate biopsy.Fluoroquinolone-based antimicrobial prophylaxis in patients undergoing transrectal ultrasound-guided prostate biopsy.Prevalence of antimicrobial resistance in normal rectal flora of patients undergoing transrectal ultrasonography-guided prostate biopsy in Korea.Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound-guided prostate biopsy.Urological oncology in the BJUI.Rational antibiotic sustainability for transrectal prostate biopsy prophylaxis.Preoperative urine culture is unnecessary in asymptomatic men prior to prostate needle biopsy.Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: A prospective multicenter study.Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy
P2860
Q26749124-9AA61716-0383-4CE5-9ABA-00316125E91CQ36395252-F86A10ED-C5DF-4A99-B904-903949A36147Q36421317-CFCA8948-04EB-4A88-8EC0-F4F1468F1693Q38175326-D03B3E37-50D0-4FF5-994B-5082648EE9D6Q38194656-74D35768-CC33-4EBB-AD2A-A38A920D937FQ38205368-0288D01F-1507-4A10-810C-E2E48C486350Q38406134-F233A57D-E086-4400-87FA-B47D3F0D43E7Q38407501-009B121B-7FF8-4C94-A538-B79719FAFB12Q38474665-71D013BF-464E-4D1B-8C4E-0639B143CF2DQ38532513-B3885EEF-5F82-446D-903C-FCBA395EB6A5Q38662109-5BA57347-5AD8-4CE9-82D7-8FF160C18E1CQ38675981-9D41C8C6-1EE3-4A7A-94D2-8CFC2F922334Q38948160-2782C518-296B-4025-AF29-C0653ECDF718Q39337754-BC7A8317-C1E6-4B6C-9F28-CAF3D287E429Q40109539-13C90877-6094-4353-B7EC-7258F1FD3861Q40126565-5D1E71BA-027A-4E96-AA71-5A97705BD488Q40168017-8F09CDF5-5113-4320-8326-D4D5A23A97D1Q40321242-BE194E04-1E25-4065-B7E6-01010ABC00ACQ40323637-9A4D1646-0B9B-43CD-9AD4-6FDDBCCEF2D1Q40649146-C5C431B1-84A7-42AE-9A42-85CA33570ED3Q40984656-DDEDC8F9-2C6B-4165-8DDC-1361384E1C27Q41181147-614C7DB4-F155-4B82-A246-3038EEA26B00Q43462473-3F0DE049-211B-4A2E-9CEB-0F9401C27C52Q44392161-90E49F28-F38C-4897-A2AC-D2C79593753FQ45180361-B3472DC7-61D5-4C5B-BBB8-091A00DC7566Q49615648-A9708FC6-6024-469A-B4F9-E0CA51DD20D1Q49686283-56A8513E-2CB0-431D-91BA-C0FD354D6190Q53087894-C6C4706E-241A-446B-909D-47066FF715A5Q58704818-C966CD5A-9195-426C-9718-B406E8184303
P2860
Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Ciprofloxacin resistance in th ...... asound guided prostate biopsy.
@en
Ciprofloxacin resistance in th ...... asound guided prostate biopsy.
@nl
type
label
Ciprofloxacin resistance in th ...... asound guided prostate biopsy.
@en
Ciprofloxacin resistance in th ...... asound guided prostate biopsy.
@nl
prefLabel
Ciprofloxacin resistance in th ...... asound guided prostate biopsy.
@en
Ciprofloxacin resistance in th ...... asound guided prostate biopsy.
@nl
P2093
P2860
P921
P1433
P1476
Ciprofloxacin resistance in th ...... asound guided prostate biopsy.
@en
P2093
Diane Roscoe
Dirk Lange
Joseph Margolick
Lindsay Machan
Peter Black
Robert Bell
S Larry Goldenberg
Stephen Taylor
William R Bowie
Zeid Abughosh
P2860
P304
P356
10.1111/J.1464-410X.2012.11637.X
P577
2013-03-06T00:00:00Z